The company said that the Canadian patent provides protection covering Javelin’s intranasal ketamine drug into 2015. Generally, Canadian ketamine patent covers the use of nasally administered ketamine to
The company said that the New York location, situated on the campus of Westchester Medical Center, will offer convenient access to specialty and traditional medications to the more
The first patient found suitable for inclusion in the Stable dissection clinical trial was a 60-year-old male diagnosed with a type B dissection of his thoracic aorta. The
Under the terms of the settlement, Palatin retains all rights to bremelanotide, its peptide in clinical development for male erectile dysfunction and female sexual dysfunction, with no obligations
The company said that the Flo-Pred (prednisolone acetate oral suspension) brand, for which there are no generic equivalents, will be sold by prescription as an anti-inflammatory agent for
The primary objective of this study comparing C2L to Sandostatin LAR was met with both C2L and Sandostatin LAR inducing a highly statistically significant decrease of insulin-like growth
The AbioCor implantable replacement heart is intended to replace the severely damaged native heart for patients who are not eligible for a transplant and have no other treatment
William Wells, CEO of ViewRay, said: “This substantial funding from blue-chip biomedical investors is a first in our industry and a testament to the promise of ViewRay’s technology
As an initial indication, the company intends to submit an investigational new drug (IND) application seeking FDA permission to enter a Phase III clinical trial of Revimmune usage
The company said that the filing of the new drug application (NDA) indicates that the registration package is sufficiently complete to allow for a thorough review of the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.